Suppr超能文献

拉莫三嗪治疗心境障碍

Lamotrigine in mood disorders.

作者信息

Green Ben

机构信息

Department of Psychiatry, University of Liverpool, UK.

出版信息

Curr Med Res Opin. 2003;19(4):272-7. doi: 10.1185/030079903125001703.

Abstract

Lamotrigine is an anticonvulsant drug with good efficacy and safety in the treatment of epilepsy. There is now substantial evidence that lamotrigine is also useful in treating resistant depression, rapid cycling bipolar affective disorder, depressive episodes in bipolar affective disorder and in the maintenance phase or prophylaxis of bipolar affective disorder. There are possible roles in managing mood changes in borderline personality disorder, reducing chronic pain and treating schizoaffective disorder. The general range of doses found effective in affective disorders is from 50 to 300 mg daily. Clinical use seems to involve a titration of dose upwards over several weeks until the desired effect is obtained. However, further definitive double-blind, randomised controlled trials against gold standard treatments are required. Lamotrigine has a preferable side-effect profile compared to standard agents for bipolar affective disorder such as lithium or carbamazepine. Further research is certainly warranted and, given its tolerability, could point to lamotrigine as the treatment of choice for some affective disorders.

摘要

拉莫三嗪是一种抗惊厥药物,在治疗癫痫方面具有良好的疗效和安全性。现在有大量证据表明,拉莫三嗪在治疗难治性抑郁症、快速循环型双相情感障碍、双相情感障碍的抑郁发作以及双相情感障碍的维持期或预防方面也很有用。在管理边缘型人格障碍的情绪变化、减轻慢性疼痛和治疗分裂情感性障碍方面可能也有作用。在情感障碍中发现有效的一般剂量范围是每天50至300毫克。临床使用似乎需要在几周内逐步增加剂量,直到获得预期效果。然而,还需要针对金标准治疗进行进一步明确的双盲随机对照试验。与双相情感障碍的标准药物如锂盐或卡马西平相比,拉莫三嗪具有更有利的副作用谱。进一步的研究当然是有必要的,而且鉴于其耐受性,拉莫三嗪可能会成为某些情感障碍的首选治疗药物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验